Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.01.2024 | Case report

Everolimus

Symmetrical drug-related intertriginous and flexural exanthema

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kim EY, et al. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema. Acta Dermato-Venereologica 103: Jan 2023. Available from: URL: https://dx.doi.org/10.2340/actadv.v103.12197 Kim EY, et al. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema. Acta Dermato-Venereologica 103: Jan 2023. Available from: URL: https://dx.doi.org/10.2340/actadv.v103.12197
Metadaten
Titel
Everolimus
Symmetrical drug-related intertriginous and flexural exanthema
Publikationsdatum
01.01.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52823-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Palbociclib